| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |